Aberrant methylation of the VIM promoter in uterine cervical squamous cell carcinoma

Oncology (Switzerland)

Volumn 86, Issue 5-6, 2014, Pages 359-368

  Lee, Min Kyung ^a   Jeong, Eun Mi ^a   Kim, Jae Hyung ^b   Rho, Seung Bae ^c   Lee, Eun Ju ^a  

^a Chung Ang University College of Medicine   (South Korea)

^b Inje University College of Medicine   (South Korea)

^c National Cancer Center   (South Korea)

Author keywords

Cervical cancer; Methylation; Prognosis; VIM

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL FEATURE; DISEASE FREE SURVIVAL; FEMALE; GENE; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MEDICAL RECORD; PRIORITY JOURNAL; PROMOTER REGION; PYROSEQUENCING; SQUAMOUS CELL CARCINOMA; STUDENT T TEST; TUMOR GENE; UTERINE CERVIX CARCINOMA; VIM GENE; CANCER TISSUE; CHROMOSOME 10P; CONTROLLED STUDY; DNA METHYLATION; GENETIC ANALYSIS; HELA CELL LINE; UTERINE CERVICAL SQUAMOUS CELL CARCINOMA; UTERUS CARCINOMA;

ADULT; AGED; BASE SEQUENCE; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; DNA METHYLATION; FEMALE; GENETIC ASSOCIATION STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PROGNOSIS; PROMOTER REGIONS, GENETIC; PROPORTIONAL HAZARDS MODELS; SEQUENCE ANALYSIS, DNA; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS; VIMENTIN; YOUNG ADULT;

GENOMIC DNA;

EID: 84902301279     PISSN: 00302414     EISSN: 14230232     Source Type: Journal    
DOI: 10.1159/000362738     Document Type: Article

References (24)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D: Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90
2. Pisani P, Bray F, Parkin DM: Estimates of the world-wide prevalence of cancer for 25 sites in the adult population. Int J Cancer 2002; 97: 72-81
3. Quinn MA, Benedet JL, Odicino F, Maisonneuve P, Beller U, Creasman WT, Heintz AP, Ngan HY, Pecorelli S: Carcinoma of the cervix uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecology Obstet 2006; 95(suppl 1):S43-S103
4. Widschwendter A, Muller HM, Fiegl H, Ivarsson L, Wiedemair A, Muller-Holzner E, Goebel G, Marth C, Widschwendter M: DNA methylation in serum and tumors of cervical cancer patients. Clin Cancer Res 2004; 10: 565-571
5. Cheung TH, Lo KW, Yim SF, Chan LK, Heung MS, Chan CS, Cheung AY, Chung TK, Wong YF: Epigenetic and genetic alternation of PTEN in cervical neoplasm. Gynecol Oncol 2004; 93: 621-627
6. Mitra S, Mazumder Indra D, Basu PS, Mondal RK, Roy A, Roychoudhury S, Panda CK: Alterations of RASSF1a in premalignant cervical lesions: Clinical and prognostic significance. Mol Carcinog 2012; 51: 723-733
7. Lof-Ohlin ZM, Sorbe B, Wingren S, Nilsson TK: Hypermethylation of promoter regions of the APC1a and p16INK4a genes in relation to prognosis and tumor characteristics in cervical cancer patients. Int J Oncol 2011; 39: 683-688
8. Jo H, Kang S, Kim JW, Kang GH, Park NH, Song YS, Park SY, Kang SB, Lee HP: Hypermethylation of the COX-2 gene is a potential prognostic marker for cervical cancer. J Obstet Gynaecol Res 2007; 33: 236-241
9. Fuchs E, Weber K: Intermediate filaments: Structure, dynamics, function, and disease. Annu Rev Biochem 1994; 63: 345-382
10. Osborn M, Weber K: Actin paracrystal induction by forskolin and by db-cAMP in CHO cells. Exp Cell Res 1984; 150: 408-418
11. Thiery JP: Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002; 2: 442-454
12. Jung S, Yi L, Kim J, Jeong D, Oh T, Kim CH, Kim CJ, Shin J, An S, Lee MS: The role of vimentin as a methylation biomarker for early diagnosis of cervical cancer. Mol Cells 2011; 31: 405-411
13. Chen WD, Han ZJ, Skoletsky J, Olson J, Sah J, Myeroff L, Platzer P, Lu S, Dawson D, Willis J, Pretlow TP, Lutterbaugh J, Kasturi L, Willson JK, Rao JS, Shuber A, Markowitz SD: Detection in fecal DNA of colon cancer-specific methylation of the nonexpressed vimentin gene. J Natl Cancer Inst 2005; 97: 1124-1132
14. Gilles C, Polette M, Mestdagt M, Nawrocki- Raby B, Ruggeri P, Birembaut P, Foidart JM: Transactivation of vimentin by beta-catenin in human breast cancer cells. Cancer Res 2003; 63: 2658-2664
15. Fuyuhiro Y, Yashiro M, Noda S, Kashiwagi S, Matsuoka J, Doi Y, Kato Y, Kubo N, Ohira M, Hirakawa K: Clinical significance of vimentin- positive gastric cancer cells. Anticancer Res 2010; 30: 5239-5243
16. Takemura K, Hirayama R, Hirokawa K, Inagaki M, Tsujimura K, Esaki Y, Mishima Y: Expression of vimentin in gastric cancer: A possible indicator for prognosis. Pathobiology 1994; 62: 149-154
17. Williams AA, Higgins JP, Zhao H, Ljunberg B, Brooks JD: CD 9 and vimentin distinguish clear cell from chromophobe renal cell carcinoma. BMC Clin Pathol 2009; 9: 9
18. Shirahata A, Sakata M, Sakuraba K, Goto T, Mizukami H, Saito M, Ishibashi K, Kigawa G, Nemoto H, Sanada Y, Hibi K: Vimentin methylation as a marker for advanced colorectal carcinoma. Anticancer Res 2009; 29: 279-281
19. Kitamura YH, Shirahata A, Sakata M, Goto T, Mizukami H, Saito M, Ishibashi K, Kigawa G, Nemoto H, Sanada Y, Hibi K: Frequent methylation of vimentin in well-differentiated gastric carcinoma. Anticancer Res 2009; 29: 2227-2229
20. Huber MA, Azoitei N, Baumann B, Grunert S, Sommer A, Pehamberger H, Kraut N, Beug H, Wirth T: NF-kappaB is essential for epithelial- mesenchymal transition and metastasis in a model of breast cancer progression. J Clin Invest 2004; 114: 569-581
21. Thompson EW, Paik S, Brunner N, Sommers CL, Zugmaier G, Clarke R, Shima TB, Torri J, Donahue S, Lippman ME, et al: Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines. J Cell Physiol 1992; 150: 534-544
22. Sommers CL, Byers SW, Thompson EW, Torri JA, Gelmann EP: Differentiation state and invasiveness of human breast cancer cell lines. Breast Cancer Res Treat 1994; 31: 325-335
23. Gilles C, Polette M, Piette J, Birembaut P, Foidart JM: Epithelial-to-mesenchymal transition in HPV-33-transfected cervical keratinocytes is associated with increased invasiveness and expression of gelatinase A. Int J Cancer 1994; 59: 661-666
24. Kitamura Y, Shirahata A, Sakuraba K, Goto T, Mizukami H, Saito M, Ishibashi K, Kigawa G, Nemoto H, Sanada Y, Hibi K: Aberrant methylation of the Vimentin gene in hepatocellular carcinoma. Anticancer Res 2011; 31: 1289-1291.